Vir Biotechnology Inc (NASDAQ: VIR) on Tuesday, plunged -1.97% from the previous trading day, before settling in for the closing price of $6.10. Within the past 52 weeks, VIR’s price has moved between $4.95 and $14.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 423.44% over the past five years. The company achieved an average annual earnings per share of 12.21%. With a float of $88.05 million, this company’s outstanding shares have now reached $136.96 million.
Let’s look at the performance matrix of the company that is accounted for 408 employees. In terms of profitability, gross margin is 86.84%, operating margin of -707.97%, and the pretax margin is -715.51%.
Vir Biotechnology Inc (VIR) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vir Biotechnology Inc is 36.22%, while institutional ownership is 50.88%. The most recent insider transaction that took place on Apr 03 ’25, was worth 474,239. In this transaction Chief Executive Officer of this company sold 79,712 shares at a rate of $5.95, taking the stock ownership to the 769,505 shares. Before that another transaction happened on Apr 03 ’25, when Company’s Officer and Director proposed sale 79,712 for $5.95, making the entire transaction worth $474,239.
Vir Biotechnology Inc (VIR) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.83 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.12% during the next five years compared to -18.74% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Vir Biotechnology Inc (VIR) is currently performing well based on its current performance indicators. A quick ratio of 8.71 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.83, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -3.23 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Vir Biotechnology Inc (NASDAQ: VIR) saw its 5-day average volume 0.96 million, a negative change from its year-to-date volume of 1.86 million. As of the previous 9 days, the stock’s Stochastic %D was 76.45%. Additionally, its Average True Range was 0.41.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 10.84%, which indicates a significant decrease from 76.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.66% in the past 14 days, which was lower than the 99.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.01, while its 200-day Moving Average is $8.20. Nevertheless, the first resistance level for the watch stands at $6.06 in the near term. At $6.15, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.21. If the price goes on to break the first support level at $5.91, it is likely to go to the next support level at $5.85. Assuming the price breaks the second support level, the third support level stands at $5.76.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
Market capitalization of the company is 825.62 million based on 138,064K outstanding shares. Right now, sales total 74,210 K and income totals -521,960 K. The company made 12,370 K in profit during its latest quarter, and -104,590 K in sales during its previous quarter.
